Growth Metrics

Stereotaxis (STXS) Research & Development (2010 - 2026)

Stereotaxis (STXS) reported Research & Development of $2.4 million for Q1 2026, up 2.0% year-over-year from $2.4 million in Q1 2025, and down 11.55% on a QoQ basis from $2.7 million in Q4 2025.

Stereotaxis (STXS) has 17 years of Research & Development data on file, last reported at $2.4 million in Q1 2026.

  • Quarterly Research & Development rose 2.0% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (down 4.43% YoY) and the FY2025 annual result came in at $9.4 million, down 3.86% from the prior year.
  • Research & Development eased to $2.4 million in Q1 2026 per STXS's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.9 million in Q2 2022 and bottomed at $1.8 million in Q2 2025.
  • The 5-year median for Research & Development is $2.5 million (2024), against an average of $2.5 million.
  • The widest annual swing landed in 2024, when Research & Development climbed 26.13%; it then retreated 21.82% in 2025.
  • Tracing STXS's Research & Development over 5 years: stood at $2.4 million in 2022, then slipped by 7.83% to $2.2 million in 2023, then climbed by 26.13% to $2.8 million in 2024, then retreated by 2.87% to $2.7 million in 2025, then declined by 11.55% to $2.4 million in 2026.
  • Per Business Quant, the three latest STXS Research & Development figures stand at $2.4 million (Q1 2026), $2.7 million (Q4 2025), and $2.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 361.90 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 249.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 94.27 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 15.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 189.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 44.30 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 98.66 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 139.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn 2.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.40 Mn
Dec 31, 2025 2.71 Mn
Sep 30, 2025 2.55 Mn
Jun 30, 2025 1.78 Mn
Mar 31, 2025 2.35 Mn
Dec 31, 2024 2.79 Mn
Sep 30, 2024 2.45 Mn
Jun 30, 2024 2.27 Mn
Mar 31, 2024 2.24 Mn
Dec 31, 2023 2.21 Mn
Sep 30, 2023 2.67 Mn
Jun 30, 2023 2.65 Mn
Mar 31, 2023 2.75 Mn
Dec 31, 2022 2.40 Mn
Sep 30, 2022 2.82 Mn
Jun 30, 2022 2.89 Mn
Mar 31, 2022 2.45 Mn
Dec 31, 2021 2.62 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.72 Mn
Mar 31, 2021 2.37 Mn
Dec 31, 2020 2.10 Mn
Sep 30, 2020 1.95 Mn
Jun 30, 2020 1.98 Mn
Mar 31, 2020 2.11 Mn
Dec 31, 2019 1.62 Mn
Sep 30, 2019 1.75 Mn
Jun 30, 2019 2.70 Mn
Mar 31, 2019 2.96 Mn
Dec 31, 2018 2.22 Mn
Sep 30, 2018 2.00 Mn
Jun 30, 2018 2.03 Mn
Mar 31, 2018 1.96 Mn
Dec 31, 2017 1.73 Mn
Sep 30, 2017 1.62 Mn
Jun 30, 2017 1.76 Mn
Mar 31, 2017 1.60 Mn
Dec 31, 2016 1.30 Mn
Sep 30, 2016 1.30 Mn
Jun 30, 2016 1.42 Mn
Mar 31, 2016 1.47 Mn
Dec 31, 2015 1.85 Mn
Sep 30, 2015 1.49 Mn
Jun 30, 2015 1.42 Mn
Mar 31, 2015 1.49 Mn
Dec 31, 2014 1.13 Mn
Sep 30, 2014 1.21 Mn
Jun 30, 2014 1.31 Mn
Mar 31, 2014 1.50 Mn
Dec 31, 2013 1.36 Mn
Sep 30, 2013 1.30 Mn
Jun 30, 2013 1.48 Mn
Mar 31, 2013 1.53 Mn
Dec 31, 2012 1.48 Mn
Sep 30, 2012 1.90 Mn
Jun 30, 2012 2.20 Mn
Mar 31, 2012 2.83 Mn
Dec 31, 2011 2.65 Mn
Sep 30, 2011 3.53 Mn
Jun 30, 2011 3.31 Mn
Mar 31, 2011 3.39 Mn
Dec 31, 2010 2.65 Mn
Sep 30, 2010 2.87 Mn
Jun 30, 2010 3.36 Mn